Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations - Drug Trials For Money - Paid Clinical Trials

TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations

TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations
Conditions:   Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations;   Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations
Intervention:   Drug: TAS-117
Sponsor:   Taiho Oncology, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 5, 2021 / by / in
Comments